Acadian Asset Management LLC Gilead Sciences, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 221,562 shares of GILD stock, worth $20.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
221,562
Previous 288,663 23.25%
Holding current value
$20.2 Million
Previous $19.8 Million 6.21%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$66.59 - $83.99 $4.47 Million - $5.64 Million
-67,101 Reduced 23.25%
221,562 $18.6 Million
Q2 2024

Aug 06, 2024
SELL
$63.15 - $72.88 $3.33 Million - $3.84 Million
-52,674 Reduced 15.43%
288,663 $19.8 Million
Q1 2024

May 10, 2024
SELL
$71.58 - $87.29 $23.3 Million - $28.4 Million
-325,625 Reduced 48.82%
341,337 $25 Million
Q4 2023

Feb 13, 2024
SELL
$73.27 - $83.09 $12.8 Million - $14.5 Million
-174,817 Reduced 20.77%
666,962 $54 Million
Q3 2023

Nov 13, 2023
SELL
$73.94 - $80.67 $67 Million - $73.1 Million
-906,707 Reduced 51.86%
841,779 $63.1 Million
Q2 2023

Aug 07, 2023
SELL
$76.01 - $86.7 $4.55 Million - $5.2 Million
-59,923 Reduced 3.31%
1,748,486 $135 Million
Q1 2023

May 11, 2023
SELL
$77.31 - $88.08 $10 Million - $11.4 Million
-129,509 Reduced 6.68%
1,808,409 $150 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $19.7 Million - $28.3 Million
-315,848 Reduced 14.01%
1,937,918 $166 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $9.09 Million - $10.4 Million
152,669 Added 7.27%
2,253,766 $139 Million
Q2 2022

Aug 09, 2022
SELL
$57.72 - $65.01 $233,477 - $262,965
-4,045 Reduced 0.19%
2,101,097 $130 Million
Q1 2022

May 12, 2022
BUY
$57.92 - $72.58 $88.7 Million - $111 Million
1,531,864 Added 267.21%
2,105,142 $125 Million
Q4 2021

Feb 10, 2022
SELL
$64.88 - $73.64 $51.2 Million - $58.1 Million
-789,280 Reduced 57.93%
573,278 $41.6 Million
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $83.2 Million - $89.8 Million
-1,229,391 Reduced 47.43%
1,362,558 $95.2 Million
Q2 2021

Aug 11, 2021
BUY
$63.47 - $69.35 $7.75 Million - $8.47 Million
122,146 Added 4.95%
2,591,949 $178 Million
Q1 2021

May 11, 2021
BUY
$60.0 - $68.46 $9.49 Million - $10.8 Million
158,183 Added 6.84%
2,469,803 $160 Million
Q4 2020

Feb 11, 2021
BUY
$56.65 - $64.55 $3.35 Million - $3.82 Million
59,190 Added 2.63%
2,311,620 $135 Million
Q3 2020

Nov 09, 2020
BUY
$62.1 - $78.08 $48.1 Million - $60.5 Million
774,961 Added 52.45%
2,252,430 $142 Million
Q2 2020

Aug 12, 2020
BUY
$72.34 - $84.0 $47 Million - $54.6 Million
649,946 Added 78.54%
1,477,469 $114 Million
Q1 2020

May 11, 2020
BUY
$62.63 - $80.22 $43.8 Million - $56.1 Million
698,896 Added 543.35%
827,523 $61.9 Million
Q4 2019

Feb 06, 2020
BUY
$61.62 - $67.78 $5.77 Million - $6.35 Million
93,685 Added 268.12%
128,627 $8.36 Million
Q3 2019

Nov 07, 2019
BUY
$62.51 - $69.0 $397,626 - $438,909
6,361 Added 22.26%
34,942 $2.21 Million
Q2 2019

Aug 08, 2019
SELL
$61.87 - $69.38 $4.1 Million - $4.59 Million
-66,194 Reduced 69.84%
28,581 $1.93 Million
Q1 2019

May 09, 2019
BUY
$62.53 - $70.05 $3.8 Million - $4.25 Million
60,691 Added 178.06%
94,775 $6.16 Million
Q4 2018

Feb 07, 2019
BUY
$60.54 - $79.0 $343,806 - $448,641
5,679 Added 19.99%
34,084 $2.13 Million
Q3 2018

Oct 30, 2018
BUY
$71.28 - $78.92 $1.39 Million - $1.53 Million
19,450 Added 217.2%
28,405 $2.19 Million
Q2 2018

Jul 24, 2018
BUY
$64.88 - $75.68 $583 - $681
9 Added 0.1%
8,955 $634,000
Q1 2018

Apr 12, 2018
SELL
$72.84 - $88.8 $1.5 Million - $1.83 Million
-20,587 Reduced 69.71%
8,946 $675,000
Q4 2017

Jan 18, 2018
BUY
$71.15 - $83.52 $242,977 - $285,220
3,415 Added 13.08%
29,533 $2.12 Million
Q3 2017

Oct 13, 2017
BUY
$72.11 - $85.47 $1.88 Million - $2.23 Million
26,118
26,118 $2.12 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email